T. Shchutska1, O. Khudaikulova1, H. Petrashenko1, N. Kurdil1, V. Zavalna1, I. Kozachko1, T. Kostiuchenko1, O. Babakin2, O. Yushchenko3
1L.I. Medved’s Research Center of Preventive Toxicology, Food and Chemical Safety, Ministry of Health, Ukraine (State Enterprise), Kyiv, Ukraine
2"Consultative and diagnostic center" Svyatoshyn district of Kyiv (Communal non-commercial enterprise), Kyiv, Ukraine
3National Children's Specialized Hospital "Okhmatdit" of the Ministry of Health of Ukraine, Kyiv, Ukraine
ABSTRACT. In Ukraine, among chronic diseases, pathology of the musculoskeletal system is one of the most frequent problems, and about 3.5 million people have problems with the musculoskeletal system and its various complications, which require
continuous therapy throughout life.
Aim. Generalization of the results of a comprehensive sanitary and hygienic assessment of the safety for consumers of a dietary supplement created to support the normal functioning of joints; data analysis of electronic publishers Scopus, Web of Science, PubMed, other foreign and domestic sources of scientific information on the research topic.
Materials and Methods. The dietary supplement "Rheumacare Ultra" has been tested for the content of heavy metals and pesticides for compliance with the State Sanitary Rules and Regulations of Ukraine. The microbiological safety of the dietary supplement was controlled by the content of mesophilic aerobic and facultative anaerobic microorganisms. The method of ultra-high-performance high-speed mass spectrometric liquid chromatography with electron spray ionization (UPLC-MC/MC, Waters, USA) and the gas chromatography method were used to determine the content of pesticide residues; the content of lead, cadmium, mercury was determined by the atomic emission method (instrument ‒ atomic emission spectrometer "SHIMADSU ICPE ‒ 9820").
Results. Based on expert assessment of documentation, analysis of data sources of scientific information, results of sanitarychemical, radiological and sanitary-microbiological studies, it was established that dietary supplement "Rheumacare Ultra" ("Rheumacare Ultra") is safe for the health of consumers and can be used for purpose: to promote the normalization of metabolism, optimization of the chemical composition of the diet, creation of optimal dietary conditions to support the normal functioning of the musculoskeletal system, in particular ‒ joints; to purposefully affect the growth of the level of adaptation capabilities of the human body in conditions of constantly increasing harmful effects of the environment.
Conclusions. Assessing the safety of traditional Ayurvedic recipes is a difficult task due to the multicomponent composition of organic-mineral complexes and the lack of complete information on the chemical structure of biologically active components
of endemic plants and their impact on human health.
Keywords: dietary supplements, sanitary and hygienic assessment, musculoskeletal system, joints.
СПИСОК ВИКОРИСТАНИХ ДЖЕРЕЛ / REFERENCES
1. WHO. Musculoskeletal health. 2021. URL: https://www.who.int/news-room/fact-sheets/detail/musculoskeletal-conditions.
2. Іпатов А.В., Мороз О.М., Ханюкова І.Я. та ін. Основні показники інвалідності та діяльності медико-соціальних експертних комісій України за 2020 рік: аналітико-інформаційний довідник / за ред. керівника експертної групи з медико-соціальної експертизи Директорату якості життя Р. Я. Перепеличної. – Дніпро: Акцент ПП, 2021. – 188 с. ISBN 978-966-921-223-8. Ipatov AV, Moroz OM, Khanyukova IY, et al. The main indicators of disability and activity of medical and social expert commissions of Ukraine for 2020: analytical and informational guide / edited by head of the expert group on medical and social expertise of the Quality of Life Directorate R.Ya. Quail - Dnipro: Accent PP, 2021. - 188 p. ISBN 978-966-921-223-8.
3. Основні показники інвалідності та діяльності медико-соціальних експертних комісій України за 2018 рік: аналітико-інформаційний довідник / А.В. Іпатов, О.М. Мороз, Н.О. Гондуленко [та ін.]. – Дніпро : Акцент ПП, 2019. – 180 с. Main indicators of disability and activity of medical and social expert commissions of Ukraine for 2018: analytical and informational guide / A.V. Ipatov, O.M. Moroz, N.O. Hondulenko [et al.]. – Dnipro: Accent PP, 2019. – 180 p.
4. Долгополов ОВ, Полішко ВП, Ярова МЛ. Епідеміологія захворювань кістково-мязової системи в Україні за період 1993-2017 рр. Вісник ортопедії, травматології та протезування. 2019. №4:101- 108. DOI: 10.37647/0132-2486-2019-103-4-96-104. Dolgopolov OV, Polishko VP, Yarova ML. Epidemiology of diseases of the musculoskeletal system in Ukraine for the period 1993-2017. Bulletin of Orthopedics, Traumatology and Prosthetics. 2019. No. 4:101-108. DOI: 10.37647/0132-2486-2019-103-4-96-104.
5. Singh A, Malhotra S, Subban R. Anti-Inflammatory and Analgesic Agents from Indian Medicinal Plants. International Journal of Integrative Biology. 2008. 3, 57-72.
6. Kalsi V, Mukhtar HM, Dubey S. Medicinal properties and health benefits of guggul-Commiphora mukul. AIP Conf. Proc. 2023. 2800, 020158. URL: https://doi.org/10.1063/5.0167758.
7. Raut OP, Mishra SK. Oleo gum resin guggulu: A reviews of the medicinal evidence for its therapeutic properties. Int. Res. Ayurveda. Pharm. 3, 2012:15-21. URL: https://www.researchgate.net/ publication/273620336.
8. Jeksy MJ, Jayaram P, Babu TD, Raghavamenon AC. Antioxidant and Anti-inflammatory Properties of a Nontoxic Herbal formulation – GSTC. Int. J. Pharm Tech Res.2014,6(3): 924-932. URL: https://sphinxsai.com/2014/phvolpt3/1/(924-932)JulAug14.pdf.
9. Ammon H P T. Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases. Wien Med Wochenschr. 2002;152(15-16):373-8. doi: 10.1046/j.1563-258x.2002.02056.x.
10. Singh GB, Singh S, Bani S. Anti-inflammatory actions of boswellic acids. Phytomed 1996;3(1):81-85. 152(15-16):373-378.
11. Wildfeuer A, Neu IS, Safayhi H, et al. Effects of boswellic acids extracted from a herbal medicine on the biosynthesis of leukotrienes and the course of experimental autoimmune encephalomyelitis. Arzneimittelforschung. 1998;48(6):668-674.
12. Sharma ML, Bani S, Singh GB. Anti-arthritic activity of boswellic acids in bovine serum albumin (BSA)-induced arthritis. Int J Immunopharmacol. 1989;11(6):647-652.
13. Singh GB, Atal CK. Pharmacology of an extract of salai guggal ex-Boswellia serrata, a new non-steroidal anti-inflammatory agent. Agents Actions 1986;18(3-4): 407-412.
14. Knaus U, Wagner H. Effects of boswellic acid of Boswellia serrata and other triterpenic acids on the complement system. Phytomedicine 1996;3(1):77-80.
15. Chaturvedi D, Dwivedi PK, Chaturvedi AK, Mishra N, Siddiqui HH, Mishra V. Semisynthetic hybrids of boswellic acids: a novel class of potential anti-inflammatory and anti-arthritic agents. Medicinal Chemistry Research. 2015. Volume 24:2799–2812.
16. Sharma ML, Kaul A, Khajuria A, et al. Immunomodulatory activity of boswellic acids (pentacyclic triterpene acids) from Boswellia serrata. Phytother Res 1996; 10:107-112.
17. Sharma ML, Khajuria A, Kaul A, et al. Effect of salai guggal ex-Boswellia serrata on cellular and humoral immune responses and leucocyte migration. Agents Actions 1988;24(1-2):161-164.
18. Atal CK, Gupta OP, Singh GB. Salai guggal: A promising anti-arthritic and anti-hyperlipidemic agent. Proc BPS 1981;203P-204P
19. Essa MM, Subramanian P. Protective role of Pongamia pinnata leaf extract on tissue antioxidant status and lipid peroxidation in ammonium chlorideinduced hyperammonemic rats. Toxicology Mechanisms and Methods. 2006; 16(9):477-483.
20. Patil P, Prasad K, Nitin M, Rao KS. Anti-ulcer and anti-secretory properties of the Pongamia Pinnata root extract with relation to anti-oxidant studies. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2010; 1:235-244.
21. Punitha R, Manohar S. Antihyperglycemic and antilipid peroxidative effects of Pongamia pinnata (Linn.) Pierre flowers in alloxan induced diabetic rats. J Ethnopharmacol. 2006; 105:39-46.
22. Srinivasan K, Muruganandan S, Lal J, Chandra S, Tandan SK, Raviprakash V. Evaluation of anti-inflammatory activity of Pongamia pinnata leaves in rats. Journal of Ethanopharmacology. 2001; 78:151-57.
23. Padhye S, Dandawate P, Yusufi M, Ahmad A, Sarkar F.H. Perspectives on medicinal properties of plumbagin and its analogs. Med. Res. Rev. 2012, 32, 1131– 1158.
24. Thakor N, Janathia B. Plumbagin: A potential candidate for future research and development. Curr. Pharm. Biotechnol. 2022, 23, 1800–1812.
25. Petrocelli G, Marrazzo P, Bonsi L, Facchin F, Alviano F, et al. Plumbagin, a Natural Compound with Several Biological Effects and Anti-Inflammatory Properties. Life. 2023. 13(6), 1303; https://doi.org/10.3390/life13061303.
26. Yadav AM, Bagade MM, Ghumnani S, Raman S, Saha B, et al. The phytochemical plumbagin reciprocally modulates osteoblasts and osteoclasts. Biol. Chem. 2021, 403, 211–229.
27. Mukjerjee S, Karati D. A mechanistic view on phytochemistry, pharmacognostic properties, and pharmacological activities of phytocompounds present in Zingiber officinale: A comprehensive review. Pharmacological Research - Modern Chinese Medicine. Volume 5, December 2022, 100173. https://doi.org/10.1016/j.prmcm.2022.100173.
28. Bitari A, Oualdi I, Touzani R, Elachouria M, Legssyer A. Zingiber officinale Roscoe: A comprehensive review of clinical properties. Materials Today: Proceedings. Volume 72, Part 7, 2023, P. 3757-3767. doi.org/10.1016/j.matpr.2022.09.316.
29. Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis Rheum. 2001. 44(11). pp. 2531-2538
30. Rajan I, Narayanan N, Rabindran R, Jayasree PR, Kumar PRM. Zingerone protects against stannous chlorideinduced and hydrogen peroxide- induced oxidative DNA damage in vitro. Biol. Trace Elem. Res. 155 (2013), pp. 455-459.
31. Chang CL, Lin CS. Development of antioxidant activity and pattern recognition of Terminalia chebula Retzius extracts and its fermented products. HungKuang J 2010; 61: 115-129.
32. Naik GH, Priyadarsini KI, Naik DB, Gangabhagirathi R, Mohan H. Studies on the aqueous extract of Terminalia chebula as a potent antioxidant and a probable radioprotector. Phytomedicine 2004; 11(6): 530-538.
33. Mahesh R, Bhuvana S, Begum VM. Effect of Terminalia chebula aqueous extract on oxidative stress and antioxidant status in the liver and kidney of young and aged rats. Cell Biochem Funct 2009; 27(6): 358-363.
34. Hazra B, Sarkar R, Biswas S, Mandal N. Comparative study of the antioxidant and reactive oxygen species scavenging properties in the extracts of the fruits of Terminalia chebula, Terminalia belerica and Emblica officinalis. BMC Comp Alter Med 2010; 10:20.
35. Lee HS, Won NH, Kim KH, Lee H, Jun W, Lee KW. Antioxidant effects of aqueous extract of Terminalia chebula in vitvo and in vitro. Biol Pharm Bull 2005; 28(9): 1639-1644.
36. Lee HS, Jung SH, Yun BS, Lee KW. Isolation of chebulic acid from Terminalia chebula Retz. and its antioxidant effect in isolated rat hepatocytes. Arch Toxicol 2007; 81(3): 211-218.
37. Chen X, Sun F, Ma L, Wang J, Qin H, Du G. In vitro evaluation on the antioxidant capacity of triethylchebulate, an aglycone from Terminalia chebula Retz fruit. Indian J Pharmacol 2011; 43(3):320-323.
38. Mishra S, Aeri V, Gaur PK, Jachak SM. Phytochemical, Therapeutic, and Ethnopharmacological Overview for a Traditionally Important Herb: Boerhavia diffusa Linn. Biomed Res Int. 2014; 2014: 808302. doi: 10.1155/2014/808302
39. Darsini DTP, Sasikumar JM, Kulandhaivel M. In Vitro Antioxidant and Cytotoxic Analysis of Boerhaavia diffusa Linn. Ethnobotanical Leaflets. 2009. 13: 263-68. URL: https://opensiuc.lib.siu.edu/cgi/viewcontent.cgi?article=1351&context=ebl/
40. Mungantiwar AA, Nair AM, Kamal KK, Saraf MN. Adaptogenic activity of aqueous extract of the roots of Boerhaavia diffusa linn. Indian Drugs, vol. 41, no. 4, pp. 184 – 189, 1997.
41. Muntgantiwar AA, A. Nair M, Shinde UA, Saraf MN. Effect of stress on plasma and adrenal cortisol levels and immune responsiveness in rats: modulation by alkaloidal fraction of Boerhaavia diffusa. Fitoterapia, vol. 68, no. 6, pp. 498–500, 1997.
42. Sumanth M, Mustafa SS. ntistress, adoptogenic and immunopotentiating activity roots of Boerhaavia diffusa in mice. International Journal of Pharmacology, vol. 3, no. 5, pp. 416–420, 2007.
43. Nguyen, Tu Thanh Thi; Do, Phuong Thi; Pham, Anh Van Thi; Nguyen, Huong Giang Thi Tran; Nguyen, Lan Ngoc Thi; Nguyen, Trang Tuyet. Phytochemical investigation on Vitex negundo leaves and their anti-inflammatory and analgesic activities. Braz. J. Pharm. Sci. 2022;58: e19463. P.1-24. Doi: 10.1590/s2175-97902022e19463.
44. Pavithra TK, Smitha KP, Kulashekar KS, Kumar A. Evaluation of invitro Anti-Arthritic Activity of Vitex negundo against the Denaturation of Protein. Int. J. Curr. Microbiol. App. Sci. (2015) 4(9): 87-90. URL: http://www.ijcmas.com.
45. Bhukta P, Ranajit SK, Sahu PK, Rath D. Phytochemistry and pharmacology of Curculigo orchioides Gaertn: A review. Journal of Applied Pharmaceutical Science 13 (10); 2023: 083-091. DOI: 10.7324/JAPS.2023.135164.
46. Bui-Le TN, Hoang-Tan Q, Hoang-Viet H, Truong-Thi BP, Nguyen-Thanh T. Protective Effect of Curculigo orchioides Gaertn. Extract on Heat Stress-Induced Spermatogenesis Complications in Murine Model. Curr Issues Mol Biol. 2023 Apr 7;45(4):3255-3267. doi: 10.3390/cimb45040212.
47. Pradeep G, Atul K. A review on phytochemical and pharmacological profile on Curculigo orchioides. Plant Cell Bio-Technol. Mol. Biol. 2020, 21, 243–252.
48. Liu M, Li Y, Yang S.-T. Curculigoside Improves Osteogenesis of Human Amniotic Fluid-Derived Stem Cells. Stem Cells Dev. 2014, 23, 146–154.
49. Tan S, Xu J, Lai A, Cui R, Bai R, et al. Curculigoside exerts significant anti-arthritic effects in vivo and in vitro via regulation of the JAK/STAT/NF-κB signaling pathway. Mol. Med. Rep. 2019, 19, 2057–2064.
50. Закон України «Про основні принципи та вимоги до безпечності та якості харчових продуктів» від 23.12.1997 № 771/97-ВР в редакції Закону № 1602-VII від 22.07.2014 р. з урахуванням змін, що внесені відповідно до Закону України «Про внесення змін до деяких законів України щодо вдосконалення державного регулювання продовольчої безпеки та розвитку тваринництва» № 3221-IX. URL: https://zakon.rada.gov.ua/laws/show/771/97-%D0%B2%D1%80#Text. / The Law of Ukraine "On Basic Principles and Requirements for the Safety and Quality of Food Products" dated 12/23/1997 No. 771/97-BP as amended by Law No. 1602-VII dated 22.07.2014, taking into account the changes introduced in accordance with the Law of Ukraine "On amending some laws of Ukraine regarding the improvement of state regulation of food safety and development of animal husbandry" No. 3221-IX. URL: https://zakon.rada.gov.ua/laws/show/771/97-%D0%B2%D1%80#Text.
51. Державні санітарні правила і норми «Максимально допустимі рівні окремих забруднюючих речовин у харчових продуктах», затвердженим Наказом МОЗ України від 22.05.2020р. № 1238, зареєстрованим в Міністерстві юстиції України 21 липня 2020 р. за № 684/3467. URL: https://zakon.rada.gov.ua/laws/show/z0684-20#Text. / State sanitary rules and norms "Maximum permissible levels of certain pollutants in food products", approved by the Order of the Ministry of Health of Ukraine dated May 22, 2020. No. 1238, registered with the Ministry of Justice of Ukraine on July 21, 2020 under No. 684/3467. URL: https://zakon.rada.gov.ua/laws/show/z0684-20#Text.
52. Наказ МОЗ України від 19.12.2013 № 1114 «Про затвердження Гігієнічних вимог до дієтичних добавок» (зареєстрованому в Міністерстві юстиції України 27 грудня 2013 р. за № 2231/24763). URL: https://zakon.rada.gov.ua/laws/show/z2231-13#Text. / Order of the Ministry of Health of Ukraine dated December 19, 2013 No. 1114 "On approval of Hygienic requirements for dietary supplements" (registered at the Ministry of Justice of Ukraine on December 27, 2013 under No. 2231/24763). URL: https://zakon.rada.gov.ua/laws/show/z2231-13#Text.
53. Тимчасові гігієнічним нормативи вмісту контамінантів хімічної і біологічної природи у біологічно активних добавках ГН 4.4.8.073-2001, затвердженим постановою Головного державного санітарного лікаря України № 131 від 20.04.2001 р. URL: https://zakon.rada.gov.ua/rada/show/v0329282-04#Text. / Temporary hygienic standards for the content of chemical and biological contaminants in biologically active additives ГН 4.4.8.073-2001, approved by the resolution of the Chief State Sanitary Doctor of Ukraine No. 131 dated 04/20/2001. URL: https://zakon.rada.gov.ua/rada /show/v0329282-04#Text.
54. ГН 6.6.1.1-130-2006 «Допустимі рівні вмісту радіонуклідів 137Cs і 90Sr у продуктах харчування та питній воді», затвердженими Наказом МОЗ України від 03.05.2006 № 256, зареєстрованим в Міністерстві юстиції України 17.07.2006 р., № 845/12719. URL: https://zakon.rada.gov.ua/laws/show/z0845-06#Text. , GN 6.6.1.1-130-2006 "Permissible levels of radionuclides 137Cs and 90Sr in food and drinking water", approved by the Order of the Ministry of Health of Ukraine No. 256 dated 05.03.2006, registered in the Ministry of Justice of Ukraine on 07.17.2006, No. 845/12719 . URL: https://zakon.rada.gov.ua/laws/show/z0845-06#Text.
55. Наказ МОЗ України від 03.09.2017 № 1073 «Про затвердження Норм фізіологічних потреб населення України в основних харчових речовинах та енергії» (зареєстрованим в Міністерстві юстиції України 02 жовтня 2017 р., №1206/31074). URL: https://zakon.rada.gov.ua/laws/show/z1206-17#Text. / Order of the Ministry of Health of Ukraine dated September 3, 2017 No. 1073 "On approval of the norms of physiological needs of the population of Ukraine in basic food substances and energy" (registered in the Ministry of Justice of Ukraine on October 2, 2017, No. 1206/31074). URL: https://zakon.rada.gov.ua/laws/show/z1206-17#Text.
56. Наказ МОЗ України від 15.05.2020 № 1145 «Про затвердження Вимог до тверджень про поживну цінність харчових продуктів та тверджень про користь для здоров'я харчових продуктів» (зареєстрованому в Міністерстві юстиції України 04 серпня 2020 р., №745/35028). URL: https://zakon.rada.gov.ua/laws/show/z0745-20#Text. / Order of the Ministry of Health of Ukraine dated May 15, 2020 No. 1145 "On Approval of Requirements for Claims on the Nutritional Value of Food Products and Claims on the Health Benefits of Food Products" (registered at the Ministry of Justice of Ukraine on August 4, 2020, No. 745/35028). URL: https://zakon.rada.gov.ua/laws/show/z0745-20#Text.
57. Наказ МОЗ України № 1613 від 16.07.2020 «Про затвердження Правил додавання вітамінів, мінеральних речовин та деяких інших речовин до харчових продуктів» (Зареєстрованому в Міністерстві юстиції України 16 вересня 2020 р.,№ 891/35174). URL: https://zakon.rada.gov.ua/laws/show/z0891-
20#Text. / Order of the Ministry of Health of Ukraine No. 1613 dated 16.07.2020 "On approval of the Rules for the addition of vitamins, minerals and certain other substances to food products" (Registered at the Ministry of Justice of Ukraine on September 16, 2020, No. 891/35174). URL: https://zakon.rada.gov.ua/laws/show/z0891-20#Text.
Стаття надійшла до редакції 12 червня 2024 р.
Received June, 12, 2024.